Clinical Trials Related to Allogene Therapeutics

Related studies linked through entity extraction aliases.

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Status: RECRUITING
Phase: PHASE1

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Status: RECRUITING
Phase: PHASE2

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)

Status: COMPLETED
Phase: PHASE1